Come up with a name for your new list and we'll add to it:
Bellicum Pharmaceuticals raised a round of funding on March 25, 2011. Investors include
Cancer Prevention and Research Institute of Texas.
Bellicum Pharmaceuticals is developing stem cell transplant, TCR, and CAR T cell therapies. Its product candidates incorporate molecular switches designed to allow activation or elimination of therape…